Capital Research Global Investors Alnylam Pharmaceuticals, Inc. Put Options Transaction History
Capital Research Global Investors
- $463 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ALNY
# of Institutions
654Shares Held
111MCall Options Held
2.14MPut Options Held
1.91M-
Capital World Investors Los Angeles, CA16.5MShares$4.37 Billion0.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.6MShares$3.34 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.53 Billion0.05% of portfolio
-
Wellington Management Group LLP Boston, MA6.21MShares$1.64 Billion0.28% of portfolio
-
Baillie Gifford & CO4.89MShares$1.29 Billion1.03% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $32.6B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...